Taf + Emtricitabine + Darunavir + Cobicistat Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Darunavir- 800 mg + Cobicistat-1 50 mg + Emtricitabine- 200 mg + TAF-10 mg
Reference Brands: Symtuza(Eu & US)
Category: Anti Viral
Symtuza is a once-daily, complete HIV-1 treatment with Darunavir, Cobicistat, Emtricitabine, and TAF. FDA and EMA approved, it offers high resistance protection and improved safety in a single-tablet regimen.
Product Description:
Symtuza is the first once-daily, single-tablet regimen combining Darunavir 800 mg, Cobicistat 150 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide (TAF) 10 mg for the treatment of HIV-1 infection. Approved by both the FDA and EMA, Symtuza is indicated for adults and adolescents (≥12 years, ≥40 kg) who are treatment-naïve or virologically suppressed. The high resistance barrier of Darunavir, boosted by Cobicistat, makes Symtuza ideal for durable viral suppression. Its TAF backbone ensures better renal and bone safety than older TDF-based regimens. Symtuza offers the simplicity of a PI-based single-tablet regimen, enhancing long-term adherence.
Taf + Emtricitabine + Darunavir + Cobicistat — third party manufacturing & bulk supply
Taf + Emtricitabine + Darunavir + Cobicistat is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Taf + Emtricitabine + Darunavir + Cobicistat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Taf + Emtricitabine + Darunavir + Cobici... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
This combination is used for the treatment of HIV-1 infection. It works by suppressing viral replication, increasing CD4 cell counts, and helping achieve long-term viral suppression when used as part of antiretroviral therapy.
It is made from the active ingredients tenofovir alafenamide (TAF), emtricitabine, darunavir, and cobicistat. TAF and emtricitabine are nucleoside reverse transcriptase inhibitors, darunavir is a protease inhibitor, and cobicistat is a pharmacokinetic enhancer.
A known trade name for this four-drug fixed combination is Symtuza in the USA, EU, and UK.
Symtuza is manufactured by Janssen (Johnson & Johnson) in collaboration with Gilead Sciences.
The generic name is tenofovir alafenamide + emtricitabine + darunavir + cobicistat.
The main brand name is Symtuza.
It is manufactured by Janssen in the EU/USA, with production also handled through their authorized global manufacturing partners.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
